KDx Diagnostics, a pioneering medical device company, announced on Thursday that it entered into strategic collaborations with leading distributors in Europe.
The collaboration indicates a significant milestone for KDx as the company continues with its aim to make early and accurate bladder cancer detection accessible globally.
The company's newly established distribution partners in Europe include LabForce AG, covering Switzerland, and MCT Lifesciences, covering United Kingdom.
Brain+ launches Ayla CST Assistant following UK regulatory approval
Accelerate Diagnostics receives FDA clearance for automated blood culture system
Photocure's partner Asieris presents Cevira Phase III subgroup analysis at 2024 CSCO Annual Meeting
Boston Scientific's FARAPULSE Pulsed Field Ablation system receives Japanese regulatory approval
Implantica advances RefluxStop with CE mark study results and prepares for FDA submission
Arrowhead Pharmaceuticals seeks approval for ARO-INHBE obesity study
Nicox and Glaukos sign exclusive research and licensing option agreement
Creo Medical forms strategic partnership with Micro-Tech via EUR36.7m subsidiary sale
Epitomee Medical's Capsule cleared by FDA for weight management
Eurofins strengthens biopharma testing in US with Infinity Labs acquisition